Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


05.06.2017

1 AJR Am J Roentgenol
3 Anticancer Res
1 BMC Cancer
2 BMC Urol
1 Br J Radiol
3 Cancer
1 Eur Radiol
3 Eur Urol
1 Int J Cancer
1 Int J Oncol
2 Int J Urol
1 J Nucl Med
4 J Urol
2 Nat Rev Urol
1 Oncol Rep
1 PLoS One
1 Prog Urol
2 Prostate
1 Radiology
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. MATSUOKA Y, Ishioka J, Tanaka H, Kimura T, et al
    Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer.
    AJR Am J Roentgenol. 2017 Jun 1:W1-W9. doi: 10.2214/AJR.16.17163.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. FITZPATRICK C, Lynch O, Marignol L
    68Ga-PSMA-PET/CT Has a Role in Detecting Prostate Cancer Lesions in Patients with Recurrent Disease.
    Anticancer Res. 2017;37:2753-2760.
    PubMed     Text format     Abstract available

  3. HONDA M, Yogosawa S, Kamada M, Kamata Y, et al
    A Novel Near-infrared Fluorescent Protein, iRFP720, Facilitates Transcriptional Profiling of Prostate Cancer Bone Metastasis in Mice.
    Anticancer Res. 2017;37:3009-3013.
    PubMed     Text format     Abstract available

  4. HU JC, Hung SC, Ou YC
    Assessments of Neoadjuvant Hormone Therapy Followed by Robotic-Assisted Radical Prostatectomy for Intermediate- and High-Risk Prostate Cancer.
    Anticancer Res. 2017;37:3143-3150.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. TAN G, Qiu M, Chen L, Zhang S, et al
    JS-K, a nitric oxide pro-drug, regulates growth and apoptosis through the ubiquitin-proteasome pathway in prostate cancer cells.
    BMC Cancer. 2017;17:376.
    PubMed     Text format     Abstract available


    BMC Urol

  6. CHUNG HS, Kim MS, Cho YH, Hwang EC, et al
    A rare presentation of metastatic prostate cancer, initially a suspect for urothelial cell carcinoma of the ureter: a case report.
    BMC Urol. 2017;17:37.
    PubMed     Text format     Abstract available

  7. BELLO JO
    Predictors of survival outcomes in native sub Saharan black men newly diagnosed with metastatic prostate cancer.
    BMC Urol. 2017;17:39.
    PubMed     Text format     Abstract available


    Br J Radiol

  8. GASNIER A, Parvizi N
    Updates on the diagnosis and treatment of prostate cancer.
    Br J Radiol. 2017 May 30:20170180. doi: 10.1259/bjr.20170180.
    PubMed     Text format     Abstract available


    Cancer

  9. WANG H, Hoda RS, Faquin W, Rossi ED, et al
    FNA biopsy of secondary nonlymphomatous malignancies in salivary glands: A multi-institutional study of 184 cases.
    Cancer. 2017;125:91-103.
    PubMed     Text format     Abstract available

  10. ADAMO MP, Boten JA, Coyle LM, Cronin KA, et al
    Validation of prostate-specific antigen laboratory values recorded in Surveillance, Epidemiology, and End Results registries.
    Cancer. 2017;123:697-703.
    PubMed     Text format     Abstract available

  11. GOKCE MI, Wang X, Frost J, Roberson P, et al
    Informed decision making before prostate-specific antigen screening: Initial results using the American Cancer Society (ACS) Decision Aid (DA) among medically underserved men.
    Cancer. 2017;123:583-591.
    PubMed     Text format     Abstract available


    Eur Radiol

  12. ROUVIERE O, Melodelima C, Hoang Dinh A, Bratan F, et al
    Stiffness of benign and malignant prostate tissue measured by shear-wave elastography: a preliminary study.
    Eur Radiol. 2017;27:1858-1866.
    PubMed     Text format     Abstract available


    Eur Urol

  13. REICHARD CA, Chapin BF
    Local Therapy for Disseminated Prostate Cancer: Improved Outcomes or Biased Confounders?
    Eur Urol. 2017 May 25. pii: S0302-2838(17)30404.
    PubMed     Text format    

  14. WILT TJ, Dahm P
    Value of Prostate Cancer Care: New Information on New Therapies Suggest Less is More.
    Eur Urol. 2017 May 29. pii: S0302-2838(17)30451.
    PubMed     Text format    

  15. DERLIN T, von Klot CA, Hueper K
    Re: Sungmin Woo, Chong Hyun Suh, Sang Youn Kim, Jeong Yeon Cho, Seung Hyup Kim. Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. In press. ht
    Eur Urol. 2017 May 29. pii: S0302-2838(17)30469.
    PubMed     Text format    


    Int J Cancer

  16. AL-QATATI A, Akrong C, Stevic I, Pantel K, et al
    Plasma microRNA signature is associated with risk stratification in prostate cancer patients.
    Int J Cancer. 2017 Jun 1. doi: 10.1002/ijc.30815.
    PubMed     Text format     Abstract available


    Int J Oncol

  17. BILIR B, Sharma NV, Lee J, Hammarstrom B, et al
    Effects of genistein supplementation on genomewide DNA methylation and gene expression in patients with localized prostate cancer.
    Int J Oncol. 2017 May 24. doi: 10.3892/ijo.2017.4017.
    PubMed     Text format     Abstract available


    Int J Urol

  18. NAKAJIMA K, Edenbrandt L, Mizokami A
    Bone scan index: A new biomarker of bone metastasis in patients with prostate cancer.
    Int J Urol. 2017 May 26. doi: 10.1111/iju.13386.
    PubMed     Text format     Abstract available

  19. ENATSU N
    Editorial Comment to Assessment of sexual function in Japanese men with prostate cancer undergoing permanent brachytherapy without androgen deprivation therapy: Analysis from the Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Impl
    Int J Urol. 2017 May 31. doi: 10.1111/iju.13383.
    PubMed     Text format    


    J Nucl Med

  20. OSMAN MM, Iravani A, Hofman MS, Hicks RJ, et al
    Detection of Synchronous Primary Malignancies with 68Ga-PSMA PET/CT in Patients with Prostate Cancer: Frequency in 764 Patients.
    J Nucl Med. 2017 Jun 1. pii: jnumed.117.190215. doi: 10.2967/jnumed.117.190215.
    PubMed     Text format     Abstract available


    J Urol

  21. TOMBAL B, Cornel EB, Persad R, Stari A, et al
    Clinical Outcomes and Testosterone Levels Following Continuous Androgen Deprivation in Patients with Relapsing or Locally Advanced Prostate Cancer: A Post Hoc Analysis of the ICELAND Study.
    J Urol. 2017 May 25. pii: S0022-5347(17)74503-X. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available

  22. FELDMAN AS, Meyer CP, Sanchez A, Krasnova A, et al
    Morbidity and Mortality of Locally Advanced Prostate Cancer: A Population-Based Analysis Comparing Radical Prostatectomy Versus External Beam Radiation.
    J Urol. 2017 May 25. pii: S0022-5347(17)74504-1. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available

  23. LEE DJ, Mallin K, Graves AJ, Chang SS, et al
    Recent changes in prostate cancer screening practices and prostate cancer epidemiology.
    J Urol. 2017 May 25. pii: S0022-5347(17)74517-X. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available

  24. TELOKEN PE, Li J, Woods CG, Cohen RJ, et al
    The impact of prostate cancer zonal origin on pathological parameters at radical prostatectomy and subsequent biochemical failure.
    J Urol. 2017 May 26. pii: S0022-5347(17)74541-7. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  25. SIDAWAY P
    Prostate cancer: AZGP1 expression predicts favourable outcomes.
    Nat Rev Urol. 2017 May 31. doi: 10.1038/nrurol.2017.
    PubMed     Text format    

  26. THOMA C
    Prostate cancer: Lineage predicts ADT response.
    Nat Rev Urol. 2017 May 31. doi: 10.1038/nrurol.2017.
    PubMed     Text format    


    Oncol Rep

  27. HATA S, Nomura T, Iwasaki K, Sato R, et al
    Hypoxia-induced angiopoietin-like protein 4 as a clinical biomarker and treatment target for human prostate cancer.
    Oncol Rep. 2017 May 24. doi: 10.3892/or.2017.5669.
    PubMed     Text format     Abstract available


    PLoS One

  28. TENNILL TA, Gross ME, Frieboes HB
    Automated analysis of co-localized protein expression in histologic sections of prostate cancer.
    PLoS One. 2017;12:e0178362.
    PubMed     Text format     Abstract available


    Prog Urol

  29. RIOUX-LECLERCQ N, Comperat E, Kammerer-Jacquet SF, Camparo P, et al
    [Pathological advances in renal, prostatic, bladder and testis neoplasia].
    Prog Urol. 2016 Jul 26. pii: S1166-7087(16)30070.
    PubMed     Text format     Abstract available


    Prostate

  30. MORI K, Kimura T, Onuma H, Kimura S, et al
    Lactate dehydrogenase predicts combined progression-free survival after sequential therapy with abiraterone and enzalutamide for patients with castration-resistant prostate cancer.
    Prostate. 2017 May 30. doi: 10.1002/pros.23373.
    PubMed     Text format     Abstract available

  31. KIM Y, Park SE, Moon JW, Kim BM, et al
    Downregulation of androgen receptors by NaAsO2 via inhibition of AKT-NF-kappaB and HSP90 in castration resistant prostate cancer.
    Prostate. 2017 May 30. doi: 10.1002/pros.23370.
    PubMed     Text format     Abstract available


    Radiology

  32. CHEVILLET JR, Khokhlova TD, Giraldez MD, Schade GR, et al
    Release of Cell-free MicroRNA Tumor Biomarkers into the Blood Circulation with Pulsed Focused Ultrasound: A Noninvasive, Anatomically Localized, Molecular Liquid Biopsy.
    Radiology. 2016 Nov 1:160024.
    PubMed     Text format     Abstract available


    Urology

  33. HEGDE JV, Veruttipong D, Said JW, Reiter RE, et al
    Prostate Cancer Antigen 3 (PCA3) Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-Free Survival in Clinically-Localized, Intermediate- and High-Risk Prostate Cancer.
    Urology. 2017 May 25. pii: S0090-4295(17)30565.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: